MUMBAI, India, June 24 -- Intellectual Property India has published a patent application (202617059653 A) filed by Fortvita Biologics Singapore Pte. Ltd. on May 11, 2026, for Anti-Il-4ra/Tslp Antibodies And Uses Thereof.

Inventors include Xiong, Yao; Li, Li; Zhou, Shuaixiang; Zhu, Mengzhu; and Fu, Jie.

The application for the patent was published on June 12, 2026, under issue no. 24/2026.

Abstract: Provided are anti-IL-4Ra antibodies or antigen-binding fragments thereof, anti-TSLP antibodies or antigen-binding fragments thereof, antigen-binding protein constructs (e. g., multi-specific or bispecific antibodies capable of specifically binding to IL-4Ra and TSLP). Provided are polynucleotides encoding the antibodies or antigen-binding prot...